Recombinant Mouse Il2ra Protein, His (Fc)-Avi-tagged
Cat.No. : | Il2ra-4513M |
Product Overview : | Recombinant Mouse Il2ra with His (Fc)-Avi tag was expressed and purified |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Mouse |
Tag : | His&Fc&Avi |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method |
Purity : | ≥85% by SDS-PAGE |
Stability : | Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
Storage Buffer : | PBS buffer |
Gene Name : | Il2ra interleukin 2 receptor,alpha chain [ Mus musculus ] |
Official Symbol : | Il2ra |
Synonyms : | Il2ra; interleukin 2receptor, alpha chain; CD25; Il2r; Ly-43; interleukin-2receptor subunit alpha; IL2-RA; IL-2-RA; p55 chain; IL-2R alpha chain; IL-2Rsubunit alpha; IL-2 receptor subunit alpha; Interleukin-2 receptor alpha subunit |
Gene ID : | 16184 |
mRNA Refseq : | NM_008367 |
Protein Refseq : | NP_032393 |
UniProt ID : | Q544I2 |
Products Types
◆ Recombinant Protein | ||
IL2RA-4C | Recombinant Canine IL2RA Protein, His (Fc)-Avi-tagged | +Inquiry |
IL2RA-5198H | Recombinant Human IL2RA Protein | +Inquiry |
IL2RA-1633H | Recombinant Human IL2RA protein, His-Avi-tagged, Biotinylated | +Inquiry |
IL2RA-942R | Recombinant Rat IL2RA Protein (Met1-Gln235), His-tagged | +Inquiry |
IL2RA-1632H | Active Recombinant Human IL2RA protein, Fc-Avi-tagged, Biotinylated, MALS verified | +Inquiry |
◆ Lysates | ||
IL2RA-2907HCL | Recombinant Human IL2RA cell lysate | +Inquiry |
IL2RA-2024MCL | Recombinant Mouse IL2RA cell lysate | +Inquiry |
IL2RA-1015CCL | Recombinant Cynomolgus IL2RA cell lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewSecurity is very high and can be used with confidence.
Structure is very stable and not prone to mutation.
The amount of expression is very high and can be easily detected.
Q&As (6)
Ask a questionThe combination of IL2RA and other drugs may produce nausea, vomiting, rash and other adverse reactions, should be monitored.
The frequency of use of IL2RA depends on the specific situation of the patient, and is generally used 1-3 times per week.
IL2RA, in the right dosage and frequency of use, can significantly relieve symptoms of diseases such as autoimmune diseases and organ transplant rejection.
Can assist in the treatment of some types of malignant tumors, but it is not a complete cure for cancer.
The effective rate of IL2RA therapy depends on many factors such as the type of disease, the patient's condition and the treatment regimen, and the effective rate is generally between 50% and 90%.
Indications of IL2RA include a variety of autoimmune diseases, organ transplant rejection and malignant tumors.
Ask a Question for All Il2ra Products
Required fields are marked with *
My Review for All Il2ra Products
Required fields are marked with *
Inquiry Basket